EPTIS
BAM Logo

Anti-TNF Drugs and Antibodies (pilot)

EPTIS factsheet 1402614 | Last revision 2025-08-07 | URL: https://www.eptis.bam.de/pts1402614 https://www.eptis.bam.de/pts1402614

PT provider
PT provider UK NEQAS for Immunology, Immunochemistry & Allergy UK NEQAS for Immunology, Immunochemistry & Allergy
Based in United Kingdom
Language(s) English
Remarks
Keywords
Product groups Health care / medical devices
Testing fields Biology
Medical analysis
Technical details
Test item Tested property Testing method
Serum TNF Adalimumab drug and antibody levels Various immunoassay techniques
-
TNF Infliximab drug and antibody levels Various immunoassay techniques
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee contact provider for prices
Regularly operated Yes (4 distributions per year)
Year of first operation 2024
Contact details of the PT provider
Provider Contact person
UK NEQAS for Immunology, Immunochemistry & Allergy
Herries Road
S5 7AU Sheffield
United Kingdom

Phone: +44 114 2715716
Fax:
Web: http://www.immqas.org.uk http://www.immqas.org.uk
Dina Patel
Phone: +44 114 2715716
Fax:
Email: ukneqas@immqas.org.uk ukneqas@immqas.org.uk
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5